OFLX

Business Context and Reporting Period

Company: Omega Flex, Inc. (OFLX)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Six months ended June 30, 2026 (unaudited)
Business Overview: Omega Flex is a leading manufacturer of flexible metal hose and accessories used in residential, commercial, and industrial applications, including gas piping and medical gases. The company operates as a single segment with manufacturing facilities in the U.S. (Pennsylvania, Texas) and the U.K. (Oxfordshire).

Key Financial Metrics

Note: The company maintains a $15 million unsecured revolving line of credit with no outstanding borrowings as of June 30, 2026.

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 3.5% year-over-year to $47.15 million, driven by market conditions.
• Margin Compression: Gross margin contracted from 60.4% to 55.8%. Management attributes this primarily to increased raw material costs, inbound transportation costs, and tariffs.
• Operating Profit Drop: Operating profit fell 38.9% to $5.36 million. While G&A expenses decreased 9.9% due to lower product liability reserves and incentive compensation, these savings were outweighed by the gross margin decline and a 13.1% increase in engineering expenses related to product development.
• Cash Flow Reduction: Operating cash flow decreased significantly to $2.38 million from $7.01 million, largely due to seasonal timing of incentive payments and changes in working capital (increases in inventory and receivables).
• Foreign Exchange Impact: The company recorded a foreign currency loss of $86,000 for the six months ended June 30, 2026, compared to a gain of $312,000 in the prior year, due to the strengthening of the U.S. dollar against the British Pound and Euro.

Outlook, Risks, and Contingencies

• Product Updates: On July 1, 2026, the company rebranded its black-jacketed CSST as "TracPipe AP CSST" and introduced a re-engineered fitting for broader applications. In August 2026, the MediTrac CMT product line received CE mark certification under EU MDR 2017/745.
• Self-Insurance Strategy: The company decided to self-insure most product liability claims for yellow-jacketed TracPipe CSST made on or after September 1, 2025. As of June 30, 2026, there were no open self-insured claims.
• Litigation Exposure: The aggregate maximum exposure for open claims (within insurance retentions) is estimated not to exceed approximately $1.17 million. The company vigorously defends against claims related to alleged lightning or electrical damage.
• Liquidity: Management believes existing cash ($47.9 million) and the $15 million credit facility are sufficient to meet needs for the next 12 months.
• Dividends: The company declared and paid regular quarterly dividends of $0.34 per share, totaling $6.86 million for the six-month period.

Investor Verification Checklist

• Margin Sustainability: Verify the trajectory of raw material and tariff costs to determine if the 4.6% gross margin compression is temporary or structural.
• Working Capital Trends: Monitor the increase in inventory ($1.33 million increase) and accounts receivable ($776 thousand increase) to ensure they align with sales volume and do not indicate collection or obsolescence issues.
• Engineering Spend ROI: Assess the return on the 13.1% increase in engineering expenses, specifically regarding the new fittings and MediTrac certification.
• Self-Insurance Risk: Review the status of self-insured claims post-September 2025 to ensure no material liabilities have emerged that could impact future profitability.
• Customer Concentration: Confirm the continued stability of the single significant customer representing over 10% of net sales and accounts receivable.